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Opitz G/BBB syndrome (OS) is a genetically heterogeneous congenital disorder 
with both X-linked and autosomal forms. Although there are established diagnostic 
criteria, the phenotypic variability among patients can be considerable. Most commonly, 
OS patients present with craniofacial, laryngotracheoesophageal, cardiac, and genital 
anomalies. OS has been linked to Xp22.3 and 22q 11.2; and additional patients with unique 
chromosomal anomalies have allowed the tentative assignment of three other autosomal 
loci at 14ql 1.2, 13q32.3ter and 5p12-13. Yet despite differing genetic bases, the clinical 
presentation in either f01m is essentially indistinguishable, despite marked variability in 
phenotypic presentation even among related family members. 
Our laboratory has previously shown that approximately 50% of patients with a 
diagnosis of OS harbour mutations in the X-linked MIDI gene. MIDI encodes a 667 amino 
acid RING finger, B-box, coiled-coil (RBCC) microtubule binding protein that is 
expressed widely throughout embryonic development and congruent with tissues affected 
in OS. A highly related protein, MID2, is the closest homologue to MID 1 and has been 
found to similarly associate with the microtubule network either as homomultimers, or as 
heteromultimers with MID 1. In this thesis, several approaches were undertaken in order to 
better understand the sub-cellular and molecular aspects of OS. Firstly, a search for MIDl-
interacting proteins was undertaken, and secondly an analysis of homologous proteins was 
completed with a view to providing insight based on the function of similar proteins. 
To identify protein partners of MID 1 that might be components of the large MID 
complexes, a yeast two-hybrid screen was performed. Using this approach, Alpha 4, a 
regulatory subunit of PP2-type phosphatases was identified as a strong interactor of MID 1 
and additionally through separate testing, MID2. Cell localisation studies showed that both 
MID 1 and MID2 tethered Alpha 4 to the microtubules. Co-expression of domain-deleted 
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and mutant forms of MID 1 with Alpha 4 localised the interaction domain of MID 1 to the 
B-boxes, which was confirmed by yeast two-hybrid assays. In addition to MID 1 and MID2 
interacting with Alpha 4, it was also found that MID 1 and MID2 interacted with one-
another through their coiled-coil domains. This further implicated MID2 as a potential 
modifier of the OS phenotype. Therefore, in order to better understand the basic functional 
aspects of MID 1 and MID2, a detailed search for other homologues was canied out. 
The RBCC tripartite (TRIM) motif skewed protein BLAST searches for N-terminal 
matches for MID 1/MID2 homologues, so combinations of N-terminal and C-te1minal 
domains were also used to identify structurally related proteins. BLAST and PSIBLAST 
searches identified the homologous proteins, TRIM9 and TRIM36 as well as partial 
transcripts of two new proteins TRIFIC and TNL (IRIM.2.-like). Subsequently, full 
sequences were determined for both of these genes. This group of six related RBCC 
proteins were designated as the RBCC C-I subfamily. To further identify sequence 
identities within the C-1 subfamily and the rest of the RBCC protein superfamily, a 
relatively novel technique using HMMER was employed. This showed that the most 
highly scoring region across the C-I subfamily was not a known domain but a region 
between the coiled-coil and Fibronectin type-III domains. This new region, called the COS 
box, was shown to be restricted to a select group of RBCC and non-RBCC proteins, all 
which associate with microtubules. Mutation of paiiicular amino acids in the COS box 
completely abolished microtubule association, and addition of a MIDI C-terminal 
fragment containing the COS box to a non-microtubule associating RBCC protein directed 
the hybrid protein to microtubules. These findings completely change the previous 
understanding that the coiled-coil or C-terminus of MID 1 and other RBCC proteins were 
responsible for microtubule association. 
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The work presented in this thesis shows that normal association of MID 1 to 
microtubules is dependent on the COS box. In addition, the B-box domain is necessary for 
tethering Alpha 4, a protein phosphatase 2A regulatory protein, to the microtubules. The 
homology of MID 1 and MID2, which extends functionally to homo and hetero-
dimerisation, microtubule association, and interaction with Alpha 4, has led to the 
suggestion of potential heterogeneity m Opitz syndrome. In this light, Alpha 4 was 
subsequently shown to be mutated m a phenotypically similar syndrome, further 
supporting the importance of the molecular interaction between these proteins. Potential 
molecular pathways in which these proteins act are discussed, as are the effects of 
disruption of these pathways, and the impact such changes may have on the development 
of key tissues affected in the diseases. 
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Chapter One: Introduction and Literature Review 
1.1 Human Congenital Disorders 
Inherited disorders are one of the most prevalent problems affecting newborns. 
Congenital abnormalities resulted in 493,000 deaths in the World Health Organisation 
member states in 2002, which equates to almost 1 in 100 births (World Health 
Organisation, 2004 statistics). However, this statistic does not include the proportion of 
newborns burdened with inherited disorders at birth that survive. For these individuals, the 
health, psychological, and financial impact on the child, family and hospital system is 
significant. These early life complications are confounded by the general lack of 
knowledge of the processes underlying the disease symptoms in the patient, hindering 
effective treatment of many disorders of this kind. To further understand and work towards 
effective health care for such individuals, it is necessary to understand the basic processes 
that occur at the molecular level within the cells of these patients. A basic understanding of 
the nature and progression of disease during embryonic development should assist 
management of patient care, improve genetic counselling services to families, provide an 
understanding of the interactions between genotype and environment which account for the 
disease phenotype, and eventually the hope of minimisation or prevention of 
malformations through early intervention strategies. 
1. 1. 1 X-linked Disorders 
Genetic disorders of X-linked origin constitute the highest proportion of congenital 
diseases attributed to a single chromosome (954 of 17088 total OMIM entries, September 
26 2006) (http://www.ncbi.nih.gov/Omim/mimstats.html). A unique feature of X-linked 
disorders is that the severity of the phenotype is dependent on the gender of the individual 
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with the mutation. The hemizygosity of the X chromosome effectively guarantees that 
males are significantly affected by any X-linked mutation since no normal allele is 
available for functional gene expression. In many respects females have a similar situation 
because only one copy of most X-linked genes is expressed in somatic cells. This occurs as 
a result of the process of X chromosome inactivation, whereby one of the two X 
chromosomes is transcriptionally silenced to ensure an equivalent gene dosage to males. 
However, X-inactivation is, in most cases, a random process, such that any particular 
female tissue is mosaic for X-linked gene expression. Specifically, some cells will express 
the alleles from one X chromosome, while other cells (which might have the other X 
chromosome remaining active), will express the other alleles. This process ensures that the 
effect of most X-linked mutations in females will be dependent on which cells express a 
mutated copy of the gene (i.e. are affected), and which cells have the mutated X inactivated 
(i.e. cells expressing the n01mal copy of the gene). The process of X-inactivation, however, 
can appear non-random or skewed in several disorders, with one X chromosome 
inactivated in preference to the other (Hedera and Gorski, 2003). This phenomenon alters 
the phenotype of the patient, making it either more severe ( akin to male presentation, if the 
normal X chromosome is preferentially inactivated) or less severe (if the mutated X 
chromosome is preferentially inactivated). Independent of any mutation or deletion 
actively causing skewed inactivation, skewing has also been associated with increasing age 
of the mother at the time of conception. As such, maternal age may affect the severity of 
the phenotype of X-linked diseases (Hatakeyama et al. , 2004). However, in most cases the 
phenotypic variability in females carrying X-linked disease-causing mutations does indeed 
suggest that X-inactivation is essentially a random process. In this state, females with X-
linked congenital disorders generally present with a mosaic pattern of affected cells nestled 
amongst cells which are normal, reflecting the clonal origin of the cells themselves. The 
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patterning of affected and normal cells may allow the tissue to compensate for dysfunction 
caused by the affected cells or maintain sufficient function, providing that the proportion 
( or positioning) of such cells does not adversely affect function of the tissue or organ. 
1.1.1.1 X chromosome anomalies 
The diagnosis of individuals presenting with particular phenotypic features 
characteristic of congenital disease can sometimes be assisted through the observation of 
karyotype, which may identify deleted and/or reananged chromosomal segments. The 
short arm of the X chromosome (Xp, Figure 1.1) is one such region of the genome that 
shows a higher than usual frequency of deletions, segmental reanangements and 
translocations that can be readily detected by standard cytogenetic techniques. In fact, it 
has been reported that this area of the X chromosome is 20 fold more likely to undergo 
recombination (and hence abnormalities of recombination: reanangement, translocation or 
deletion) compared with the genomic average (Filatov and Genard, 2003). This segmental 
instability is due to the position of a region of identity with the Y chromosome. This region 
is known as the pseudo-autosomal region and is used for pairing of the sex chromosomes 
during male meioses. A large number of locally repeated sequences present on the X 
chromosome are also believed to contribute to genomic rearrangement (Lutskiy et al. , 
2002). 
The study of human diseases resulting from such X chromosome mutations has 
been assisted by positional mapping of chromosomal breakpoints. The disorders caused by 
genomic reanangement or deletion of regions from the telomeric end of the shmt arm of 
the X chromosome are phenotypically distinct in males and generally conespond to the 
size of the anomaly. Such correlations have also been critical in determining disease loci 
within the region by physical mapping (Ballabio and Andria, 1992). 
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Figure 1.1 The Human X Chromosome. 
Xp Pseudo Autosomal 


































q28 Xq Pseudo Autosomal 
Region N429 Kbp 
The X Chromosome, seen from the Scanning Electron Microscopy (SEM) image 
(left), consists of a short 'p' arm and a long 'q' arm. Genes of interest in this project are 
located at various positions along the X chromosome and are marked on the ideogram of a 
G-banded X chromosome (right), indicating their relative positions. The pseudoautosomal 
regions (PAR), which sit at the tips of Xp and Xq, are the points of Y chromosome pairing 
during male meiosis. Note the relative close proximity between MIDI and the Xp PAR, a 
region that is 20 fold more likely than the genomic average to undergo genetic 
recombination, thought to be one cause of genetic instability in the area. 
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